Mostrar o rexistro simple do ítem

dc.contributor.authorAndreu, Ricardo
dc.contributor.authorSantos-del-Riego, Sergio
dc.contributor.authorPayri, Francisco
dc.date.accessioned2021-09-07T11:44:19Z
dc.date.available2021-09-07T11:44:19Z
dc.date.issued2021-08-20
dc.identifier.citationAndreu, R.; Santos-del-Riego, S.; Payri, F. Serum Inflammatory and Prooxidant Marker Levels in Different Periodontal Disease Stages. Healthcare 2021, 9, 1070. https://doi.org/10.3390/healthcare9081070es_ES
dc.identifier.issn2227-9032
dc.identifier.urihttp://hdl.handle.net/2183/28433
dc.description.abstract[Abstract] Background: Periodontitis has been associated to systemic diseases and this association could be due to an increase in circulating inflammatory and oxidative stress biomarkers in the periodontal disease. This study aimed to evaluate the relationship between inflammatory and pro-oxidant markers according to different stages of periodontitis. Methods: This cross-sectional study included 70 subjects who were divided into three groups according to periodontitis stage: stage II (n = 22), stage III (n = 30), and stage IV (n = 18). We evaluated periodontal parameters and levels of high-sensitivity C-reactive protein (hsCRP), fibrinogen, and malondialdehyde (MDA) in serum, and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in urine. Results: Serum hsCRP and fibrinogen levels were associated with periodontitis severity, which were higher in stage IV than in stages III and II of periodontitis (p = 0.003 and p = 0.025, respectively). We observed a slight yet insignificant increase in MDA levels related to periodontitis severity. Probing depth and clinical attachment loss were associated with serum fibrinogen and hsCRP levels. However, there were no significant associations between periodontal variables and MDA and 8-OHdG levels. Conclusion: Our data support an association between periodontitis and systemic inflammation, which increases with periodontal disease severity. This indicates the importance of the early diagnosis and treatment of periodontal disease to avoid the development or worsening of systemic inflammatory diseases.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relation.urihttps://doi.org/10.3390/healthcare9081070es_ES
dc.rightsAtribución 4.0 Internacional (CC BY 4.0)es_ES
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectPeriodontal diseaseses_ES
dc.subjectPeriodontitises_ES
dc.subjectInflammationes_ES
dc.subject8-hydroxy-2′-deoxyguanosinees_ES
dc.subjectMalondialdehyde;es_ES
dc.subjectOxidative stresses_ES
dc.titleSerum Inflammatory and Prooxidant Marker Levels in Different Periodontal Disease Stageses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/openAccesses_ES
UDC.journalTitleHealthcarees_ES
UDC.volume9es_ES
UDC.issue8es_ES
UDC.startPage1070es_ES
dc.identifier.doi10.3390/healthcare9081070


Ficheiros no ítem

Thumbnail
Thumbnail

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem